A Nigerian-born doctor, Stella Immanuel is making the headlines after her passionate plea for health practitioners across the world to use hydroxychloroquine for the treatment of Covid 19.
In a video that has one viral on social media, she argues in support of the controversial treatment despite warnings from other experts including the FDA in America.
According to the FDA in America, hydroxychloroquine or chloroquine as a treatment for COVID-19 patients had no benefits.
Other countries also halted their clinical trials into the drug stating same positions on benefits.
Stella Immanuel is part of a team of Medical professionals that attended the America’s Frontline Doctors Summit in front of the U.S. Supreme Court in Washington, D.C. on Monday, July 27.
The America’s Frontline Doctors Summit is taking place on July 27 and 28 with the goal of dispelling what it calls the “massive disinformation campaign” about COVID-19 in the U.S, according to its website.
Dr. Stella Immanuel just like other doctors spoke to the media after the summit but her statements condemning the current accepted virus treatment went viral.
Immanuel spoke of her experience treating COVID-19 patients with hydroxychloroquine and her belief in its effectiveness.
A Facebook spokesperson said “We’ve removed this video for sharing false information about cures and treatments for COVID-19.
We’re showing messages in News Feed to people who have reacted to, commented on or shared harmful COVID-19-related misinformation that we have removed, connecting them to myths debunked by the WHO.”
Immanuel later said on Twitter that “Hydroxychloroquine works if given early. President Trump we are with you. Many of us doctors know it and have used it. Don’t stop speaking up for us.”
Hydroxychloroquine works if given early. President Trump we are with you. Many of us doctors know it and have used it. Don’t stop speaking up for us. @realDonaldTrump @MarkMeadows @TuckerCarlson @IngrahamAngle @DonaldJTrumpJr @POTUS @VP @GovMikeHuckabee @PastorBroden
— Stella Immanuel MD (@stella_immanuel) April 27, 2020
Dr. Immanuel who is based in Houston, Texas is a physician at Rehoboth Medical Center in Houston.
She is also the founder of Fire Power Ministries, a religious organization who said “In the past few months, after taking in over 350 patients, we have not lost one. Not a diabetic, not somebody with high blood pressure, not somebody with asthma, not an old person. We’ve not lost one patient.”
According to Immanuel she and her staff at the clinic and “many doctors that I know” are on hydroxychloroquine as a preventative measure.
She says, “I came here to Washington, D.C. to say: America, nobody needs to die.” Immanuel says it’s upsetting to see people struggling to breathe and thinking that COVID-19 is a “death sentence.”
In May this year many African countries defied a warning from the World Health Organization on the safety of the anti-Malarial drug called hydroxychloroquine for treatment of Covid-19 patients.
The WHO had said at the time that it was halting clinical trials on the anti-malaria drug because of safety fears.
“The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board,” said WHO Director-General Tedros Adhanom Ghebreyesus.
A study published in the Lancet peer-reviewed journal looked at over 96,000 virus patients and found a higher risk of abnormal heartbeats, or arrhythmias, that could cause a heart attack in those treated with hydroxychloroquine or chloroquine.
Tedros said the Lancet report researchers found a higher mortality rate among patients receiving the drug when used alone or with a macrolide.
But in Africa many countries ignored this caution and declaring their intentions to proceed with clinical trials and using the drug to treat patients.
The director of Nigeria’s National Agency for Food and Drug Administration and Control (Nafdac), Mojisola Adeyeye said in a media interview that she does not dispute WHO’s conclusions but they want to generate their own data.
She was quoted as saying that “I do not know the data that they’re looking at, whether it’s from the Caucasian population or from the African population.
If the data they’re looking at and the reason for suspending the trials is from Caucasian population, then it may be justified. But I don’t think we have data from the African population yet, because our genetic make up is different.”